Artificial Intelligence (AI) platforms Could Enhance Jaguar Health’s development and anticipated commercialization of Crofelemer for Rare Disease Intestinal Failure (IF) Programs
April 14, 2026
Host Jon Najarian interviews CEO, Shane Schaffer. He shows us how Cingulate has been optmizing ADHD therapy.
April 14, 2026
April 8, 2026
March 15, 2023
January 18, 2023
We use cookies to improve your experience on our site, to show you personalized advertising, and as otherwise described in our Cookie Policy . To find out more, read our Privacy Policy and our Cookie Policy.